Physician profile
Donald E Poland
NPI 1437111333
$2,756.23
in general payments reported to CMS, 2019-2025
18 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.22 · 2020: $93.83 · 2021: $325 · 2022: $323 · 2023: $982 · 2024: $482 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,894 · Gift: $66.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,893.66 |
| Gift | $66.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Notal Vision, INC. | $796.47 | 2023 | |
| Abbvie INC. | $470.10 | 2024-2025 | |
| Alcon Vision LLC | $298.31 | 2021-2025 | Rocklatan, Tryptyr, Clareon |
| Allergan, INC. | $242.71 | 2020-2022 | |
| Tearlab Corp | $189.41 | 2022-2024 | |
| Glaukos Corporation | $145.92 | 2023 | |
| Dompe US, INC. | $129.68 | 2022-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $102.84 | 2024-2025 | Xdemvy |
| Amgen INC. | $71.88 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $71.11 | 2024-2025 | Vyzulta, Miebo |
| Oyster Point Pharma, INC. | $55.72 | 2022-2024 | Tyrvaya |
| Akorn, INC. | $53.22 | 2019 | |
| Ani Pharmaceuticals, INC. | $28.48 | 2025 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $22.45 | 2022 | |
| Rxsight INC | $21.48 | 2023 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $20.92 | 2024 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.29 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Poland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.